PKD Cures Act

This bill would require the National Institute of Diabetes and Digestive and Kidney Diseases (an NIH institute) to expand research on polycystic kidney disease (PKD), including basic, translational, and clinical research. The institute's director would work with other federal agencies, universities, and private groups, and would support training programs for PKD researchers and clinicians. The bill would also require the Director of NIH to set up a working group of experts and patient advocates to create a PKD research roadmap. The working group would report its findings and recommendations to Congress within 24 months.

Full text and official record on Congress.gov

Sponsors

• Debbie Wasserman Schultz Democrat sponsor
• 7 cosponsors